Manufacturing
Quality Trends
Every release in the order it was made, against its specification limits.
Releases plotted
26
ACE-MGS 20 PH · magnesium stearate, pharmaceutical grade
Average sieve residue 75 µm
0.08%
Specification 0.00 to 0.50% · target 0.10%
-0.02 against target
Outside specification
0
Every release inside its limits
Clean run
Process capability, Cpk
0.59
Spread is wide against the limits
σ 0.05%
Sieve residue 75 µm by batch, in the order it was made
Red bands are the specification limits, the dashed line is target.
Inside spec Near a limit Out of spec
Worth a look
Releases outside a limit or close to one, newest first.
| Batch | Made | Sieve residue 75 µm | On the job before | Where |
|---|---|---|---|---|
| B26-0365 ACE-MGS20-PH | 19 Jul 2026 | 0.03% Near a limit | -0.14 | WO-2026-0365 RX-03 · Malcolm Rees |
| B26-0352 ACE-MGS20-PH | 01 Jul 2026 | 0.04% Near a limit | -0.06 | WO-2026-0352 RX-03 · Malcolm Rees |
| B26-0132 ACE-MGS20-PH | 07 Feb 2026 | 0.04% Near a limit | +0.01 | WO-2026-0132 RX-03 · Anthony Jarvis |
| B26-0079 ACE-MGS20-PH | 26 Jan 2026 | 0.03% Near a limit | -0.14 | WO-2026-0079 RX-03 · Malcolm Rees |
| B26-0067 ACE-MGS20-PH | 06 Jan 2026 | 0.03% Near a limit | +0.00 | WO-2026-0067 RX-03 · Tui Faletau |
| B25-0902 ACE-MGS20-PH | 22 Dec 2025 | 0.03% Near a limit | -0.12 | WO-2025-0902 RX-03 · Anthony Jarvis |
| B25-0856 ACE-MGS20-PH | 03 Nov 2025 | 0.04% Near a limit | -0.13 | WO-2025-0856 RX-03 · Anthony Jarvis |
| B25-0738 ACE-MGS20-PH | 20 Aug 2025 | 0.02% Near a limit | -0.06 | WO-2025-0738 RX-03 · Sione Naufahu |
The biggest movement in the run
The largest change from one job to the next.